share_log

EFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW) Sees Significant Decline in Short Interest

Financial News Live ·  Jan 1, 2023 22:31

eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) was the recipient of a significant decrease in short interest in December. As of December 15th, there was short interest totalling 26,800 shares, a decrease of 23.9% from the November 30th total of 35,200 shares. Based on an average trading volume of 16,000 shares, the days-to-cover ratio is presently 1.7 days.

eFFECTOR Therapeutics Price Performance

NASDAQ EFTRW remained flat at $0.16 on Friday. The company has a fifty day moving average of $0.13 and a 200-day moving average of $0.17. eFFECTOR Therapeutics has a fifty-two week low of $0.04 and a fifty-two week high of $0.99.

Featured Stories

  • Get a free copy of the StockNews.com research report on eFFECTOR Therapeutics (EFTRW)
  • MarketBeat: Week in Review 12/26 – 12/30
  • The Dogs Of Tech: It's Time For A Bite Of These Stocks
  • Does This Acquisition Make Microsoft a Bear Market Buy?
  • Is Kintara Therapeutics A Hidden Gem?
  • Should You Warm up to Generac Stock for the Winter?

Receive News & Ratings for eFFECTOR Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eFFECTOR Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment